INSOMNIA is the #8 most commonly reported adverse reaction for Cymbalta, manufactured by Eli Lilly and Company. There are 9,750 FDA adverse event reports linking Cymbalta to INSOMNIA. This represents approximately 2.2% of all 439,614 adverse event reports for this drug.
Patients taking Cymbalta who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
INSOMNIA9,750 of 439,614 reports
INSOMNIA is a less commonly reported adverse event for Cymbalta, but still significant enough to appear in the safety profile.
Other Side Effects of Cymbalta
In addition to insomnia, the following adverse reactions have been reported for Cymbalta:
INSOMNIA has been reported as an adverse event in 9,750 FDA reports for Cymbalta. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is INSOMNIA with Cymbalta?
INSOMNIA accounts for approximately 2.2% of all adverse event reports for Cymbalta, making it a notable side effect.
What should I do if I experience INSOMNIA while taking Cymbalta?
If you experience insomnia while taking Cymbalta, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.